Screener
Pacira BioSciences, Inc. PCRX Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Interest income | 1,930 | 6,895 |
| Interest expense | (3,699) | (4,580) |
| Other, net | (135) | 4,401 |
| Total other (expense) income, net | (1,904) | 6,716 |
| Income before income taxes | 4,998 | 8,706 |
| Income tax expense | (2,082) | (3,894) |
| Net income | $2,916 | $4,812 |
| Net income per common share: |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s other income (expense)?
- Pacira BioSciences, Inc. (PCRX) reported other income (expense) of -$1.9M in Q1 2026.
- How has Pacira BioSciences, Inc.'s other income (expense) changed year-over-year?
- Pacira BioSciences, Inc.'s other income (expense) decreased by 128.4% year-over-year, from $6.72M to -$1.9M.
- What is the long-term trend for Pacira BioSciences, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s other income (expense) has grown at a -48.7% compound annual growth rate (CAGR), from -$33.52M to -$2.32M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Pacira BioSciences, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude